LB1148
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LB1148, covering 2017-11-20 to 2024-06-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection [Phase 2]